CLINICAL_TRIALS
trial_result
· 2022-10-25
Clinical Trial Update: The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. [Phase 3]
Summary
Phase 3 trial update on DWP16001 versus placebo for type 2 diabetes mellitus, reporting efficacy and safety results after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED